compounded Wegovy pill
Search documents
Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill
MarketWatch· 2026-02-06 20:29
Core Insights - Hims & Hers is launching a cancer-detection test that is prominently featured in its Super Bowl advertisement, highlighting the disparity in healthcare access for the wealthy [1] Company Summary - The company is focusing on innovative healthcare solutions, as evidenced by the introduction of the cancer-detection test [1]
Hims & Hers launch of compounded $49 Wegovy pill pummels Novo Nordisk's shares
MarketWatch· 2026-02-05 15:56
Core Insights - The compounded pill is more cost-effective compared to the oral version of Wegovy, which has a starting price of $149 [1] Cost Comparison - The compounded pill offers a less expensive alternative to the oral Wegovy, which is priced at $149 to initiate treatment [1]
VIEW Hims and Hers Health's compounded Wegovy pill offering fuels market jitters
Reuters· 2026-02-05 15:06
Core Viewpoint - Hims & Hers will start offering compounded versions of Novo Nordisk's Wegovy pill at an introductory price of $49 per month [1] Company Summary - Hims & Hers is entering the market for compounded medications by providing a version of Wegovy, which is known for weight management [1]